"Cancersensor": Circadian Rhythms
NCT01693835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2025-11-18
Summary
Observational, non randomized study aimed at measuring the circadian rhythms in the urinary concentrations of physiological modified nucleosides in 30 patients with metastatic colorectal cancer and in 30 age and sex-matched healthy subjects.
Conditions
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
Francis Lévi, MD, PhD · INSERM and AP-HP and Paris South University
-
Sandrine Dulong, PhD · Institut National de la Santé Et de la Recherche Médicale, France
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- France
Study Locations
More Related Trials
-
Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
NCT02828462 ·Status: UNKNOWN
-
A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers
NCT02552953 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
NCT01048983 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
NCT04042298 ·Status: COMPLETED
-
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer
NCT00059943 ·Status: COMPLETED ·Phase: PHASE2
-
Measuring the Impact of Onco4D® Guidance on Chemotherapy Selection and Outcomes
NCT04891952 ·Status: NOT_YET_RECRUITING
-
1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
NCT00567931 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Hospital Pharmacist on Drug Management in Patients With Bronchopulmonary Cancer
NCT06469957 ·Status: COMPLETED
-
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
NCT05123001 ·Status: COMPLETED
-
Analyses of Human Samples Collected in Clinical Trials
NCT00339664 ·Status: COMPLETED
-
Optimizing the Management of Patients With Oral Therapy
NCT03623490 ·Status: TERMINATED ·Phase: NA
-
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
NCT04091711 ·Status: SUSPENDED ·Phase: NA
-
The Validation of a Novel Adherence Method for Oral Oncolytics
NCT03561272 ·Status: COMPLETED ·Phase: NA
-
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
NCT01317550 ·Status: COMPLETED ·Phase: NA
-
Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients
NCT04641819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Acetylamantadine Excretion by Cancer Patients
NCT02277938 ·Status: UNKNOWN
-
Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)
NCT03676010 ·Status: ACTIVE_NOT_RECRUITING
-
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
NCT03563352 ·Status: WITHDRAWN
-
Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
NCT00227136 ·Status: TERMINATED ·Phase: PHASE3
-
The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study
NCT02385656 ·Status: UNKNOWN ·Phase: PHASE4
-
Symptom Burden in Head and Neck Cancer
NCT01219673 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring
NCT01053104 ·Status: COMPLETED
-
American Ginseng in Treating Patients With Fatigue Caused by Cancer
NCT00719563 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
NCT00905658 ·Status: UNKNOWN ·Phase: PHASE2
-
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
NCT03035409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2